AlphaMaven AlphaMaven

AI, biotech and new energy likely targets of HKIC yuan fund

Reported by Scmp
Jun 2, 2026· 3 min read
Save Post LinkedIn Email
Key Takeaways
  • • Hong Kong Investment Corporation (HKIC), which manages a HK$62 billion (US$8 billion) portfolio, will establish an offshore yuan-denominated venture capital fund to channel capital into emerging technology and industries, according to Financial Secretary Paul Chan Mo-po's announcement on June 2, 2026.
  • • The fund targets AI, biotechnology, health tech, new energy, green technology, fintech, and aerospace startups, with particular focus on companies with mainland China or Hong Kong founder bases seeking to leverage Hong Kong as a platform for R&D, commercialization, financing, and regional expansion.
  • • The yuan-denominated structure addresses demand from companies and investors holding offshore yuan who seek investment vehicles aligned with the currency, creating a strategic capital tool that supports Hong Kong's positioning as a financial hub for technology-driven enterprises.
  • • Fund investees are expected to establish offices in Hong Kong and prioritize the city for eventual listing, positioning the vehicle as both a commercial investment mechanism and a strategic tool supporting Hong Kong's economic development objectives.
  • • Lawmaker Robert Lee Wai-wang, chairman of Grand Finance Group, indicated this is an opportune timing for launching such a fund, suggesting market readiness for yuan-denominated venture capital targeting emerging sectors.
Summary
Hong Kong Investment Corporation, the Hong Kong government's investment arm with a HK$62 billion (US$8 billion) portfolio, will establish an offshore yuan-denominated venture capital fund to address demand from companies and investors seeking exposure to China's currency while deploying capital into high-growth sectors. Financial Secretary Paul Chan Mo-po announced the initiative on June 2, 2026, stating that "there are a lot of companies and investors who have offshore yuan, and would like to use the currency to make investments." The fund represents a strategic effort to channel this capital into cutting-edge technology and emerging industries.

According to Benjamin Quinlan, CEO and managing partner at Hong Kong-based consultancy Quinlan & Associates, HKIC has identified specific investment verticals for the fund: hardcore technology, biotechnology and health tech, new energy and green technology, and startups in artificial intelligence, fintech, and aerospace. Quinlan noted in an interview with the South China Morning Post that the fund would particularly target "companies with a mainland China or Hong Kong founder base that are looking to go global," emphasizing that Hong Kong's value proposition centers on providing these companies with infrastructure for research and development, commercialization, financing, regional expansion, and eventual listing opportunities.

The fund structure reflects HKIC's strategic expectations that investee companies establish offices in Hong Kong and prioritize the city for their public market debuts. This dual commercial and policy objective positions the yuan-denominated fund as both a return-focused investment vehicle and a tool supporting Hong Kong's broader economic development goals. Lawmaker Robert Lee Wai-wang, who chairs Grand Finance Group, indicated strong market timing for the initiative, suggesting institutional and investor appetite for yuan-denominated venture capital targeting technology-driven sectors is materially present.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Scmp AI, biotech and new energy likely targets of HKIC yuan fund